A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients (clinicaltrials.gov) - Nov 7, 2025 - P3 | N=105 | Active, not recruiting | Sponsor: Children's Oncology Group | Trial completion date: Jun 2028 ➔ Jun 2029 | Trial primary completion date: Jun 2028 ➔ Jun 2029
Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Hematological Malignancies • Infectious Disease • Oncology • Pediatrics • Solid Tumor • Transplantation
|